New research reveals that people who stop using popular slimming jabs like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who halt conventional diet and exercise plans.
Research printed in a leading health publication shows that while overweight individuals frequently drop a large proportion of their total mass while on the medication, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.
"Individuals buying such medications should be aware of the risk of fast weight regain when the therapy concludes," warns lead investigator Dr. Susan Jebb.
Such speed of recovery suggests a reversion to pre-treatment mass in about a year and a half.
Analyzing Approaches
The study, which examined dozens of studies involving thousands of patients, compared the results of the injectable medications with other pills.
Researchers point out that individuals who shed pounds through lifestyle changes alone usually have a more gradual creep back—perhaps 0.1 kg a month—once they finish.
Understanding the Fast Regain
Experts believe the mechanism of the injections accounts for the heightened rebound.
These medications mimic a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Long-term administration of GLP-1 concentrations several times higher than normal may cause the body to produce less of its own natural hormone, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this hormone supplement results in hunger is uncontrolled, making binge eating a significant risk."
An Ongoing Disease?
The NHS advise the jabs for people with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Professionals say that, given the likelihood of relapse, the treatment might need to be life-long.
This perspective is supported by pharmaceutical companies, who note that the results "emphasize the persistent character of obesity," comparing it to managing diseases like diabetes.
User Experiences
Users who have stopped the jabs report a intense return of appetite.
"It felt as if something that goes on and you become extremely hungry," said one woman.
This challenge is worsened if individuals have not established permanent lifestyle or habit modifications during therapy.
Significant Use
Figures indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with interest remaining high.
- Adoption is more common among females than males.
- The 40s and 50s demographic shows the highest usage rates.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, clinicians emphasize that while the jabs are powerful agents for shedding pounds, they are not a magic cure and lasting health benefits hinges on ongoing behavioural support.
